Latest Breaking News On - Stephaniel graff - Page 1 : comparemela.com

Revisit Every OncLive On Air Episode From April 2024

Revisit Every OncLive On Air Episode From April 2024
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkNew havenYale universityLos angelesRhode islandCity ofUnited kingdomMemorial sloan kettering cancer centerBrown universityElias bou farhatSarah rutherfordIan rabinowitzSaadz usmaniMatthew lunningBou farhar

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology

Drs Graff, Mahtani, McCann, and Rugo share moments that sparked their interest in oncology and setbacks they overcame when building their careers.

Rhode islandUnited statesBrown universityUniversity of california san franciscoAshling wahnerStephaniel graffKellye mccannReshmal mahtaniUniversity of californiaMiami cancer instituteCancer infusion servicesBreast oncology at lifespan cancer instituteDivision of hematologyHelen diller family comprehensive cancer centerBreast medical oncology at baptist health wellnessLive on air

Dr Graff on the Trajectory of Her Career in Breast Cancer

Dr Graff on the Trajectory of Her Career in Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Stephaniel graffBreast cancer translational research disease groupWarren alpert medical schoolBrown university legorreta cancer centerLifespan cancer instituteBrown universityLegorreta cancer center

Dr Graff on the Relation Between ctDNA Positivity and Disease Recurrence in HR+/HER2– Breast Cancer

Stephanie L. Graff, MD, discusses findings from a pilot study exploring the association between disease recurrence and circulating tumor DNA positivity in patients with hormone receptor–positive, HER2-negative, node-positive, high-risk, early breast cancer who have received adjuvant treatment of abemaciclib and endocrine therapy.

San antonioUnited statesStephaniel graffBreast cancer translational research disease groupWarren alpert medical schoolLifespan cancer instituteBrown university legorreta cancer centerBrown universityLegorreta cancer centerAntonio breast cancer symposiumOnclive tvBreast cancerEndocrine therapy interruptionHr positive breast cancerHer2 negative

Persistent ctDNA Correlates With Disease Recurrence in HR+/HER2– Early Breast Cancer

Detection of circulating tumor DNA with the Signatera assay was associated with disease recurrence in patients with hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer at 24 months post-randomization to treatment with adjuvant abemaciclib and endocrine therapy.

San antonioUnited statesAnn oncStephaniel graffLifespan cancer instituteLegorreta cancer center at brown universityAntonio breast cancerLegorreta cancer centerBrown universityAntonio breast cancer symposiumSan antonio breast cancer symposiumBreast cancer